跳至主要内容
临床试验/NCT04253444
NCT04253444已完成不适用

A Randomized Single Blinded Parallel Study to Investigate the Physiological Modulation of the Autonomic Nervous System on Symptoms in Patients With Reflux Hypersensitivity

Queen Mary University of London1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年4月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
The feasibility of 10 minutes twice a day for 4 weeks of slow deep breathing

研究概览

简要总结

Reflux hypersensitivity is the disease that causes chest pain, heartburn and regurgitation and can impair patients' quality of life. Pain modulators are often used for the treatment of reflux hypersensitivity, but the effect is not enough and more effective therapy is needed.

Slow deep breathing is the validated method to modulate the autonomic nervous system. In our previous study, slow deep breathing could increase the threshold of oesophageal pain in healthy volunteers. Therefore, slow deep breathing has the potential to be an effective treatment for reflux hypersensitivity and further study is warranted in the patient group.

The aims of this study are (1) to evaluate the feasibility of slow deep breathing and (2) to investigate the effect of autonomic nerve modulation by slow deep breathing on symptoms in patients with reflux hypersensitivity.

详细描述

This is a randomized single-blinded parallel study and the investigators aim to recruit 40 participants.

Patients will be enrolled for a period of 4 weeks and don't have to attend our institution. A video chat on day 1 will consist of confirming eligibility, after which the patient will be randomised to follow either the slow deep breathing protocol or the sham breathing protocol in a single blinded fashion. That is, the patient will be unaware of which the active breathing exercise is. Once randomised during a video chat, they will undergo baseline heart rate variability (HRV) measurements using a smartphone app, answer the questionnaires on Research Electronic Data Capture (REDCap), and then practice the relevant breathing exercise with an instruction video. The patient will then be trained to self-administer the breathing exercise during a video chat, which will be used twice a day for 10 minutes over the next 4 weeks with a standardized instruction video.

This study finishes when participants answer the online questionnaire and record HRV on day 29.

The investigators will set up this questionnaire on our electronic data capture system (Research Electronic Data Capture: REDCap). Participants will answer questionnaires using this online system on day 1, day 8, day15, day 22, and day 29 (end of the study).

Therefore, participants will also be trained on how to use REDCap and answer questionnaires under supervision on day 1 during a video chat. Questionnaires on day 8, 15, 22, and 29 will be answered at home. The investigators will send a reminder message to participants using a REDCap system the day before they answer the questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participants and outcomes assessors will be masked.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female patients over the age of 18 years.
  • •Women in the follicular phase of the menstrual cycle (visits will be arranged so that in menstruating women, the study will be started in the follicular phase of the menstrual cycle to standardise for possible confounding effects of the menstrual cycle on symptom perception).
  • •Able to give informed consent
  • •Able to speak and understand English without the need for an interpreter
  • •No evidence of erosive esophagitis by OGD
  • •Presence of chest pain, heartburn, and/or regurgitation ≥ 3 days/week
  • •Normal acid exposure on MII-pH
  • •Positive symptom reflux association on MII-pH (symptom index ≥ 50% and symptom association probability ≥ 95%)
  • •OGD is performed within 2 years before the enrolment
  • •MII-pH study is performed within 2 year before the enrolment

排除标准

  • •Current or previous GI or medical illnesses that may affect ANS / GI function
  • •Current or previous significant CNS illness
  • •Current medications affecting the CNS, GI or ANS systems
  • •Pregnancy and lactation
  • •Cardiac dysrhythmias
  • •Those who do not have access to the internet-based questionnaire
  • •The use of acid suppression therapies (e.g. proton pump inhibitor or H2 blocker) or pain modulators (e.g. low-dose Tricyclic Antidepressants, TCAs or Selective Serotonin Reuptake Inhibitors, SSRI) does not change the decision of participation as long as above-mentioned symptoms remain.
  • •Patients are asked to refrain from smoking for 12 hours and drinking alcohol as well as using recreational drugs for 48 hours prior to study visit.

研究组 & 干预措施

slow deep breathing

Active Comparator

Patients are instructed to do deep breathing at full inspiratory capacity for 4 seconds followed by forced expiration in 6 seconds (forced vital capacity) for 10 minutes.

干预措施: slow deep breathing (Behavioral)

sham breathing

Sham Comparator

Patients are instructed to count 10 breaths and tick a box every time they count ten breaths. The counting distracts the patient reducing the effect of focussing of breathing on their autonomic nervous system.

干预措施: sham breathing (Behavioral)

结局指标

主要结局

The feasibility of 10 minutes twice a day for 4 weeks of slow deep breathing

时间窗: 4 weeks

Compliance and acceptability are evaluated by the Global or general acceptability of treatment questionnaire. This is recorded as 'very good', 'good', 'fair', or 'poor'.

次要结局

  • The effect of slow deep breathing on anxiety(4 weeks)
  • The effect of slow deep breathing on personality states.(4 weeks)
  • The effect of slow deep breathing on depression.(4 weeks)
  • Changes in symptoms before and after slow deep breathing(4 weeks)
  • Changes in vagal nerve activity before and after slow deep breathing protocol(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验